NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









RoboCT Technology

RoboCT Technology

Private
HangzhouHealthcare & Life Scienceshttp://www.roboct.com/

Last Round

Series B

Extension

Mar 5, 2026

Total Funding Raised

$43.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

RoboCT Technology is a robotics company that develops and manufactures exoskeleton robots, mobile robots, and core components for medical rehabilitation and elderly care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics, Medical AI, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

exoskeleton robotsrehabilitation exoskeletonwearable robotmedical roboticsgait trainingmobility assistancerehab techassistive technologyrobotic rehabilitationexosuitstand-assist robotconsumer exoskeletonrobot componentspediatric exoskeletonRehabilitation-as-a-ServiceRaaSMecanum wheels

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RoboCT Technology Comparables

Compare RoboCT Technology with similar companies based on industry and business-model similarity.

RoboCT Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beijing DaAi Robot Technology Co., Ltd.
92%
Shenzhen MileBot Robotics Co., Ltd.
90%
FREE Bionics
90%

RoboCT Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionMar 5, 2026
Series BMar 27, 2025
Series A ExtensionApr 12, 2022
Series AMar 29, 2021

RoboCT Technology Investors

Notable investors and investment history

RoboCT Technology investors
InvestorRounds
ABC-CA Fund ManagementSeries B Extension
Shenzhen Dachen Caizhi Venture Capital ManagementSeries A Extension
Hangzhou State-owned Capital Investment and Operation Co., Ltd.Series B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 13, 2026

    Launched consumer series of lower limb exoskeleton products.

  • Mar 13, 2026

    Exoskeleton products displayed at the 2026 Guangzhou Welfare Exhibition.

RoboCT Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RoboCT Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RoboCT Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range16
Year Founded2017
Last FundingMar 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.